Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — March 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Mar 3, 2026
Sale
Shares
759
Price
$508.95
Total Value
$386.29K
Shares Held After
124,045
% of Holdings
0.6%
Mar 3, 2026
Sale
Shares
931
Price
$507.90
Total Value
$472.85K
Shares Held After
124,804
% of Holdings
0.7%
Mar 3, 2026
Sale
Shares
448
Price
$506.74
Total Value
$227.02K
Shares Held After
125,735
% of Holdings
0.4%
Mar 3, 2026
Sale
Shares
120
Price
$504.06
Total Value
$60.49K
Shares Held After
126,183
% of Holdings
0.1%
Mar 3, 2026
Sale
Shares
120
Price
$502.59
Total Value
$60.31K
Shares Held After
126,303
% of Holdings
0.1%
Mar 3, 2026
Sale
Shares
360
Price
$501.95
Total Value
$180.70K
Shares Held After
126,423
% of Holdings
0.3%
Mar 3, 2026
Sale
Shares
382
Price
$500.55
Total Value
$191.21K
Shares Held After
126,783
% of Holdings
0.3%
Mar 3, 2026
Sale
Shares
240
Price
$499.75
Total Value
$119.94K
Shares Held After
127,165
% of Holdings
0.2%
Mar 3, 2026
Sale
Shares
680
Price
$498.14
Total Value
$338.74K
Shares Held After
127,405
% of Holdings
0.5%
Mar 3, 2026
Sale
Shares
480
Price
$496.84
Total Value
$238.48K
Shares Held After
128,085
% of Holdings
0.4%
Mar 3, 2026
Sale
Shares
360
Price
$495.29
Total Value
$178.30K
Shares Held After
128,565
% of Holdings
0.3%

Tectonic Therapeutic, Inc. (TECX)

McNamara Peter — Chief Scientific Officer
Mar 3, 2026
Sale
Shares
1,649
Price
$22.06
Total Value
$36.38K
Shares Held After
37,482
% of Holdings
4.2%
Mar 3, 2026
Sale
Shares
1,012
Price
$80.82
Total Value
$81.79K
Shares Held After
11,014
% of Holdings
8.4%
Mar 3, 2026
Sale
Shares
6,794
Price
$80.00
Total Value
$543.49K
Shares Held After
12,026
% of Holdings
36.1%
Mar 3, 2026
Sale
Shares
13,526
Price
$79.17
Total Value
$1.07M
Shares Held After
18,820
% of Holdings
41.8%
Mar 3, 2026
Sale
Shares
68,685
Price
$32.36
Total Value
$2.22M
Shares Held After
85,616
% of Holdings
44.5%
Mar 3, 2026
Sale
Shares
12,077
Price
$32.36
Total Value
$390.81K
Shares Held After
12,823
% of Holdings
48.5%

AGIOS PHARMACEUTICALS, INC. (AGIO)

Washburn Theodore James Jr. — Principal Accounting Officer
Mar 3, 2026
Sale
Shares
5,272
Price
$28.88
Total Value
$152.26K
Shares Held After
868
% of Holdings
85.9%

IDEXX LABORATORIES INC /DE (IDXX)

Hunt Nimrata — Executive Vice President
Mar 3, 2026
Sale
Shares
1,758
Price
$634.57
Total Value
$1.12M
Shares Held After
18,141
% of Holdings
8.8%

BIOLIFE SOLUTIONS INC (BLFS)

Berard Todd — Chief Marketing Officer
Mar 3, 2026
Sale
Shares
353
Price
$20.74
Total Value
$7.32K
Shares Held After
165,940
% of Holdings
0.2%

COLLEGIUM PHARMACEUTICAL, INC (COLL)

Dreyer Scott — EVP & Chief Commercial Officer
Mar 3, 2026
Sale
Shares
3,559
Price
$40.99
Total Value
$145.88K
Shares Held After
71,770
% of Holdings
4.7%

COLLEGIUM PHARMACEUTICAL, INC (COLL)

Dreyer Scott — EVP & Chief Commercial Officer
Mar 3, 2026
Sale
Shares
46,417
Price
$40.36
Total Value
$1.87M
Shares Held After
75,329
% of Holdings
38.1%

IONIS PHARMACEUTICALS INC (IONS)

BENNETT C FRANK — EVP, Chief Scientific Officer
Mar 3, 2026
Sale
Shares
802
Price
$80.76
Total Value
$64.77K
Shares Held After
80,554
% of Holdings
1.0%

IONIS PHARMACEUTICALS INC (IONS)

BENNETT C FRANK — EVP, Chief Scientific Officer
Mar 3, 2026
Sale
Shares
12,687
Price
$79.88
Total Value
$1.01M
Shares Held After
81,356
% of Holdings
13.5%

IONIS PHARMACEUTICALS INC (IONS)

BENNETT C FRANK — EVP, Chief Scientific Officer
Mar 3, 2026
Sale
Shares
71,600
Price
$79.10
Total Value
$5.66M
Shares Held After
94,043
% of Holdings
43.2%

BIOLIFE SOLUTIONS INC (BLFS)

Wichterman Troy — Chief Financial Officer
Mar 3, 2026
Sale
Shares
588
Price
$20.74
Total Value
$12.20K
Shares Held After
220,649
% of Holdings
0.3%
Mar 3, 2026
Sale
Shares
1,005
Price
$80.80
Total Value
$81.20K
Shares Held After
3,811
% of Holdings
20.9%
Mar 3, 2026
Sale
Shares
14,608
Price
$79.88
Total Value
$1.17M
Shares Held After
4,816
% of Holdings
75.2%
Mar 3, 2026
Sale
Shares
39,265
Price
$79.11
Total Value
$3.11M
Shares Held After
19,424
% of Holdings
66.9%

BIOLIFE SOLUTIONS INC (BLFS)

Foster Karen A. — Chief Quality and Operations
Mar 3, 2026
Sale
Shares
418
Price
$20.74
Total Value
$8.67K
Shares Held After
210,665
% of Holdings
0.2%

Zai Lab Ltd (ZLAB)

Amado Rafael — President, Head of Global Oncology Research and Development
Mar 3, 2026
Sale
Shares
10,000
Price
$17.38
Total Value
$173.80K
Shares Held After
42,391
% of Holdings
19.1%

IONIS PHARMACEUTICALS INC (IONS)

Baroldi Joseph — EVP, Chief Business Officer
Mar 3, 2026
Sale
Shares
36
Price
$81.01
Total Value
$2.92K
Shares Held After
4,347
% of Holdings
0.8%

IONIS PHARMACEUTICALS INC (IONS)

Baroldi Joseph — EVP, Chief Business Officer
Mar 3, 2026
Sale
Shares
2,088
Price
$80.41
Total Value
$167.89K
Shares Held After
4,383
% of Holdings
32.3%

IONIS PHARMACEUTICALS INC (IONS)

Baroldi Joseph — EVP, Chief Business Officer
Mar 3, 2026
Sale
Shares
4,096
Price
$79.36
Total Value
$325.06K
Shares Held After
41,317
% of Holdings
9.0%

BIOLIFE SOLUTIONS INC (BLFS)

Mathew Aby J. — EVP & Chief Scientific Officer
Mar 3, 2026
Sale
Shares
529
Price
$20.74
Total Value
$10.97K
Shares Held After
392,937
% of Holdings
0.1%

BIOLIFE SOLUTIONS INC (BLFS)

Aebersold Sarah — Chief Human Resources Officer
Mar 3, 2026
Sale
Shares
219
Price
$20.74
Total Value
$4.54K
Shares Held After
93,360
% of Holdings
0.2%
Mar 3, 2026
Sale
Shares
832
Price
$80.33
Total Value
$66.83K
Shares Held After
36,330
% of Holdings
2.2%
Mar 3, 2026
Sale
Shares
21,330
Price
$13.43
Total Value
$286.44K
Shares Held After
328,397
% of Holdings
6.1%
Mar 3, 2026
Sale
Shares
50,557
Price
$12.79
Total Value
$646.45K
Shares Held After
349,727
% of Holdings
12.6%

INTUITIVE SURGICAL INC (ISRG)

Brosius Mark — SVP & Chief Mfg and Supply Cha
Mar 3, 2026
Sale
Shares
648
Price
$488.10
Total Value
$316.29K
Shares Held After
5,916
% of Holdings
9.9%

BIOLIFE SOLUTIONS INC (BLFS)

Werner Sean — Chief Technology Officer
Mar 3, 2026
Sale
Shares
111
Price
$20.74
Total Value
$2.30K
Shares Held After
49,932
% of Holdings
0.2%
Mar 3, 2026
Sale
Shares
2,000
Price
$26.00
Total Value
$52.00K
Shares Held After
19,839
% of Holdings
9.2%

IONIS PHARMACEUTICALS INC (IONS)

Devers Shannon L. — EVP, Chief Human Resources Ofc
Mar 3, 2026
Sale
Shares
755
Price
$80.84
Total Value
$61.03K
Shares Held After
22,541
% of Holdings
3.2%

IONIS PHARMACEUTICALS INC (IONS)

Devers Shannon L. — EVP, Chief Human Resources Ofc
Mar 3, 2026
Sale
Shares
5,030
Price
$80.00
Total Value
$402.39K
Shares Held After
23,296
% of Holdings
17.8%

IONIS PHARMACEUTICALS INC (IONS)

Devers Shannon L. — EVP, Chief Human Resources Ofc
Mar 3, 2026
Sale
Shares
14,321
Price
$79.11
Total Value
$1.13M
Shares Held After
28,326
% of Holdings
33.6%
Mar 3, 2026
Purchase
Shares
4,500
Price
$17.68
Total Value
$79.56K
Shares Held After
64,891
% of Holdings
6.9%

Editas Medicine, Inc. (EDIT)

Burkly Linda — EVP, CHIEF SCIENTIFIC OFFICER
Mar 3, 2026
Sale
Shares
749
Price
$2.02
Total Value
$1.51K
Shares Held After
68,028
% of Holdings
1.1%

Butterfly Network, Inc. (BFLY)

Caezza Nicholas — Deputy General Counsel
Mar 3, 2026
Sale
Shares
14,209
Price
$3.71
Total Value
$52.74K
Shares Held After
312,040
% of Holdings
4.4%

Editas Medicine, Inc. (EDIT)

Parison Amy — SVP, Chief Financial Officer
Mar 3, 2026
Sale
Shares
474
Price
$2.02
Total Value
$957.48
Shares Held After
15,434
% of Holdings
3.0%

ARTIVION, INC. (AORT)

Stanton Marshall S. — SVP, Clinical & MD Affair
Mar 3, 2026
Sale
Shares
2,149
Price
$37.78
Total Value
$81.18K
Shares Held After
60,097
% of Holdings
3.5%
Version: v26.3.33